Pacira BioSciences Total Current Liabilities

Pacira BioSciences (PCRX) currently reports a total current liabilities of $120M as of June 2026. That compares with $310M in the prior-year period — down 61.0% year over year. Use the charts on this page to explore Pacira BioSciences's total current liabilities history and peer comparisons.

Pacira BioSciences's total current liabilities decreased from $310M to $120M — a 61.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pacira BioSciences reported $120M in total current liabilities as of June 2026. That compares with $310M in the prior-year period — down 61.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pacira BioSciences, and consider following PCRX for alerts when major investors trade the stock.

Pacira BioSciences is classified in the Healthcare sector. On total current liabilities, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PCRX with unrelated industries.